Harvard Bioscience Inc. reported entering a Loan and Security Agreement on December 17, 2025, securing $40 million across three term loans (A: $10M, B: $22.5M, C: $7.5M) to repay prior debts and support operations. Notably, the Term C Loan may convert to stock if share price exceeds $1.50 for 30 days.